0001104659-23-047208.txt : 20230419 0001104659-23-047208.hdr.sgml : 20230419 20230419162850 ACCESSION NUMBER: 0001104659-23-047208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230418 FILED AS OF DATE: 20230419 DATE AS OF CHANGE: 20230419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ali Asif CENTRAL INDEX KEY: 0001921163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 23830350 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 tm2312473-2_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-04-18 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001921163 Ali Asif 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-04-18 4 F 0 1189 23.21 D 23186 D Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 3,437 vested restricted stock units on April 18, 2023. The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date. /s/ Matthew Gosling, Attorney-in-Fact for Asif Ali 2023-04-19